Ypsomed Holding AG (SWX:YPSN)

Switzerland · Delayed Price · Currency is CHF

299.50

-2.50 (-0.83%)

Feb 20, 2026, 5:31 PM CET

Revenue by Segment

Financials in millions CHF. Fiscal year is April - March.

Millions CHF. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Ypsomed Diabetes Care	236.87M	151.05M	173.53M	187.49M	177.73M
Ypsomed Diabetes Care Growth	56.82%	-12.96%	-7.45%	5.49%	-5.31%
Ypsomed Delivery Systems	502.27M	385.15M	307.81M	259.04M	211.18M
Ypsomed Delivery Systems Growth	30.41%	25.13%	18.83%	22.66%	9.97%
Others	26.60M	16.60M	18.33M	20.19M	16.22M
Others Growth	60.21%	-9.42%	-9.19%	24.43%	3.92%
Eliminations	-16.87M	-4.35M	-2.21M	-1.87M	-1.47M
Total	748.87M	548.46M	497.46M	464.84M	403.66M
Total Growth	36.54%	10.25%	7.02%	15.16%	2.38%

Revenue by Geography

Financials in millions CHF. Fiscal year is April - March.

Millions CHF. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Switzerland	88.85M	58.01M	60.80M	42.43M	35.32M
Switzerland Growth	53.16%	-4.59%	43.31%	20.13%	3.20%
Europe	446.75M	332.59M	308.88M	296.63M	269.38M
Europe Growth	34.33%	7.68%	4.13%	10.11%	-2.64%
North America	56.55M	47.51M	39.81M	41.19M	39.24M
North America Growth	19.03%	19.33%	-3.35%	4.99%	-2.32%
Others	156.72M	110.35M	87.97M	84.60M	59.72M
Others Growth	42.02%	25.44%	3.99%	41.65%	38.29%
Total	748.87M	548.46M	497.46M	464.84M	403.66M
Total Growth	36.54%	10.25%	7.02%	15.16%	2.38%

Source: S&P Global Market Intelligence.